Drugs / YiQiFang
last change Jun 2017 re-read 2 minutes ago

YiQiFang

Developed for
cancer
Investigated by
Shanghai Chest Hospital · Shanghai Pulmonary Hospital, Shanghai, China · Shanghai University of Traditional Chinese Medicine

Trials 2 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02889692 Mar 2013 → Dec 2016 cancer Shanghai University of Traditional Chinese Medicine Completed No outcome recorded
Phase 3 NCT02900742 Mar 2013 → Dec 2016 cancer Shanghai University of Traditional Chinese Medicine Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as YiQiFang ClinicalTrials.gov intervention name — accepted as the source's own label NCT02889692
1

NCT02900742

Route Oral “TCM granules: oral granules” NCT02900742